THE DEAL, AT A GLANCE
From the announcementVaderis Therapeutics
01Who is involvedBacked by SR OneFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedVaderis Therapeutics raised $152M Series B, announced 2026-08-12From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersVaderis Therapeutics' $152M Series B indicates continued Healthcare & Life Sciences capital concentration into later-stage, clinically anchored opportunities, with the…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Vaderis Therapeutics · Financing Record
Explore source-linked visual explanations for Vaderis Therapeutics. Unsupported claims are withheld while source review continues.
Record 10092 · Recorded date: 2026-08-12
Explore company records →